Male Autoimmune Infertility




© Springer International Publishing Switzerland 2017
Walter K.H. Krause and Rajesh K. Naz (eds.)Immune Infertility10.1007/978-3-319-40788-3_12


12. Male Autoimmune Infertility



Felice Francavilla  and Arcangelo Barbonetti 


(1)
Department of Life, Health and Environmental Sciences, University of L’Aquila, Coppito, 67100 L’Aquila, Italy

(2)
San Raffaele Sulmona Institute, Viale dell’Agricoltura, Sulmona, 67039, Italy

 



 

Felice Francavilla (Corresponding author)



 

Arcangelo Barbonetti



Abstract

Naturally occurring antisperm-antibodies (ASA) exert an impairment to fertility, which is related to the extent of sperm autoimmunization. It determinates the degree of the interfering effect on sperm penetration through the cervical mucus independently from the antigenic specificity of ASA. Therefore, sperm-autoimmunization relevant to infertility can be diagnosed in the presence of a high proportion of ASA-covered spermatozoa, associated with a poor result of a carefully performed postcoital test. Whether or to what extent an ASA-interfering effect occurs, in each individual patient, downstream from the impairment of cervical mucus penetration, is still hard to establish. The main reason is the inability of current diagnostic tests to determine the antigenic specificity of ASA and to quantify the antibody density on the sperm surface, which are main determinants of ASA-impairment at the level of sperm/oocyte interaction. In any case, from a clinical point of view, to establish whether, or to what extent, this ASA-interfering effect occurs, in each individual patient, is not needed to diagnose ASA-related subfertility, because such impairment cannot occur in the absence of the interference at the level of mucus penetration. But, it would be relevant in choosing the more appropriate assisted reproductive treatment option.



12.1 Introduction: Does Antisperm-Antibodies-Related Infertility Really Exist?


An etiological link between naturally occurring antisperm-antibodies (ASA) and male infertility has been claimed since Rumke [45] and Wilson [53] reported the presence of serum sperm-agglutinating activity in some infertile men in 1954. However, although the clinical significance of ASA has been extensively investigated, it is still a debated matter. On one hand, the previous assertions that any link between sperm antibody presence and impaired conception has to be considered hypothetical [49] and the routine use of current ASA testing is not justified as an essential procedure in the fertility work-up [28] were more recently reasserted in a cohort study where no independent association was observed between the occurrence of ASA and reduced pregnancy rates in subfertile couples [32]. On the other hand, intracytoplasmatic sperm injection (ICSI) has been claimed as the primary choice of treatment in the presence of sperm autoimmunization [33], and a screening test for ASA has been reconfirmed as integral part of semen analysis in the last edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen [56].

Different approaches used for the recognition of the ASA-related infertility, paucity of prospective studies on the occurrence of spontaneous pregnancies, and lack of well-designed and controlled studies on treatments effectiveness have strongly contributed to generate confusion on the clinical significance of ASA.

This chapter critically reviews current understanding of the clinical relevance of naturally occurring ASA in men.


12.2 Prevalence of Antisperm Antibodies


A variable prevalence of ASA has been reported depending on the specificity and sensitivity of the test used for their detection and on the screened population. The first assays to be utilized were indirect tests detecting biological activities of ASA in serum and seminal plasma, i.e., sperm agglutination techniques and complement-dependent sperm immobilization/cytotoxicity techniques. Subsequently, widespread acceptance has been gained for antiglobulins-based tests used to detect antibodies coated to the surface of ejaculated spermatozoa, including the mixed antiglobulin reaction (MAR) test and the immunobead binding test (IBT). They reveal the percentage of antibody-coated spermatozoa, the Ig-isotype, and grossly the regional specificity of ASA. Old multicentric comparative studies [7, 54] showed that all these tests determine in large measure the same antibody specificities for surface antigens, but with different sensitivity, which is lower for complement-dependent sperm-immobilization/cytotoxicity techniques.

In epidemiologic studies, serum sperm-agglutinating activity ranged from 8.1 to 30.3 % in unselected men with infertile marriages [13, 21, 26, 40], but at low titers it was also reported up to 10 % of control sera [26]. When stricter criteria were used (i.e., the occurrence of sperm-immobilizing activity in addition to high titers of sperm-agglutinating activity in the serum and/or sperm-agglutinating activity in seminal plasma, indicating an excess of free antibodies in the semen), the prevalence of ASA in men with infertile marriages ranged from 4.6 to 5.7 % [21, 38]. Direct tests (MAR or IBT) gave positive results (>10 or >20 %) in 7.6–12.9 % of unselected infertile patients [11, 21, 38, 47], but highly positive results (≥50 %) were restricted to 5–6 % of patients [11, 21, 47]. In the most recent and largest multicentric survey, including 1794 consecutive subfertile couples, a positive IgG-MAR ≥10 % was detected in 7 % of men and a positive IgG-MAR ≥50 % was detected in 3 % of men [32].

Although a higher prevalence of ASA has been reported in some clinical conditions, including genital tract obstructions and infections, especially by Chlamydia trachomatis, testicular trauma, torsion, and surgery (see Chap. 8), only acquired genital tract obstructions represent a well-established risk factor: in vasectomized men the prevalence of ASA ranges from 33 to 74 % [5, 19, 29, 37], with their persistence in 38–60 % following successful vasovasostomy [5, 37].


12.3 Prognostic Studies


A causal link between ASA and fertility impairment, although suggested by epidemiologic studies, can only be proven by the association of the occurrence and the degree of sperm autoimmunization with a reduced pregnancy rate, independently from semen parameters and other clinical characteristics.

In retrospective studies, when the degree of sperm-autoimmunization was taken into account, it exhibited a significant inverse correlation with the incidence of spontaneous pregnancies. In an old report by Rumke et al. [46], during a 10-year follow-up of 254 infertile men with serum sperm-agglutinating activity (SAA), the titer of SAA was inversely correlated with the occurrence of spontaneous pregnancies. Notably, restricting the analysis to normozoospermic men, no pregnancy was observed with very high titer of serum SAA (≥1:1024), a low (15.8 %) pregnancy rate (PR) with titers ranging from 1:32 to 1:512, and a high PR (48.4 %) with titers <1:32. Ayvaliotis et al. [4] reported that in 108 infertile couples where the male exhibited a direct IBT >10 %, and the female was treated for other factors leading to impaired reproduction, PR was significantly higher when IBT was <50 % than when it was >50 % (43.4 % vs. 21.8 %) during a follow-up of at least 18 months. The difference in PR was ever of greater significance in a subgroup of 35 couples, where no other cause of infertility was found (15.3 % vs. 66.7 %). Abshagen et al. [1] reported that in 157 infertile couples with a direct IBT >10 %, cumulative spontaneous PR over 6 years was high (~50 %) when IBT was <50 %, lower (~30 %) when IBT was 50–90 %, and very low (~15 %) when IBT was >90 %, independently from the IgG-class (IgG and/or IgA). A significant inverse correlation between the degree of sperm autoimmunization and PR was also found in a follow-up study of 216 men after vasovasostomy by Meinertz et al. [39]. While no pregnancy was observed in a median period of ~4 years in men where all spermatozoa were antibody-coated at MAR test, in association with a high titer of serum SAA, pregnancy occurred in 64.3 % of couples with a less degree of sperm-autoimmunization. While in this study only a prevalent IgA autoimmunization was associated to a reduced fertility, a major role of IgA was not found in another study on vasovasostomized men by Matson et al. [37].

Altogether, these observations suggest that ASA represent a relative, rather than absolute, cause of infertility and the degree of fertility impairment appears to be related to the extent of sperm-autoimmunization. Accordingly, a threshold of 50 % positivity at MAR or IBT test has been established by WHO [56] for a degree of sperm-autoimmunization which might be clinically relevant.

However, the best evidence for a causal link between ASA and fertility impairment would be provided by prospective studies comparing the occurrence of natural pregnancies in men with and without ASA. Unfortunately this evidence is difficult to obtain: (1) the low incidence of sperm autoimmunization in unselected infertile couples requires multicentric studies including a large number of infertile couples (or, for the best evidence, couples without history of infertility) and a large number of observed cycles; (2) the inter-individual variability of semen parameters, not related to the presence of ASA, makes it very difficult to obtain a study- and a control-population, homogeneous for semen quality; and (3) the inter-couples variability in other clinical characteristics. Owing to these limitations, little information along with conflicting results has been produced by scanty prospective studies so far reported [13, 18, 55]. In the most recent and largest study [32], a positive IgG-MAR test ≥50 %, detected in 3 % of 1794 patients with infertile marriages, reduced, albeit not significantly, the probability of pregnancies during a 1-year follow-up. At the multivariate analysis, including semen parameters and other clinical characteristics, a positive MAR test ≥50 % did not contribute to the prediction of spontaneous pregnancy.

Therefore, the proof of a causal link between ASA and infertility has not yet been produced by the evidence-based medicine.


12.4 Mechanisms of Fertility Impairment by Antisperm-Antibodies: Clinical Relevance


Only ASA directed towards surface antigens have a physiopathological and clinical significance in the male immunological infertility, because subsuperficial antigens cannot be exposed to antibodies by living cells along the male genital tract.


12.4.1 Effect on Semen Quality


Sperm agglutination is the only well established semen alteration related to the presence of ASA [24]. However, sperm agglutination, which is a time-dependent phenomenon, only rarely involves a large proportion of motile spermatozoa soon after liquefaction, even when all ejaculated spermatozoa are antibody-coated. Therefore, sperm agglutination, although extremely suggestive of sperm-autoimmunization, does not represent either a sensitive marker of autoimmunization or an important mechanism of the antibody-interference with fertility in most cases. Apart from sperm-agglutination, there is little evidence that suggests a cause/effect relationship between ASA and abnormality of semen parameters [24]. Actually, an effect on sperm motility/vitality should involve a complement (C)-mediated sperm injury, but it is prevented by anticomplementary activity in human seminal plasma [15, 42].


12.4.2 Interference with Cervical Mucus Penetration


The impairment of sperm penetration through the cervical mucus represents the primary, well-documented mechanism of the ASA interference with fertility. Several studies have shown a significant association between a poor postcoital test (PCT) outcome and sperm autoimmunization [6, 25, 35]. Interestingly, in the above mentioned study by Leushuis et al. [32], although the evidence for an independent association between sperm-autoimmunization and reduced pregnancy rate was not provided, a negative PCT result was significantly associated with a positive MAR test result (relative risk 2.5, 95 % CI 1.4–4.3). The degree of the impairment of sperm penetration “in vivo” through the cervical mucus was found to correlate with the proportion of antibody-covered spermatozoa [6], as well as with the titer of circulating ASA [35]. The demonstration of the actual responsibility of ASA in impairing cervical mucus penetration was provided by matching donor sperm suspensions exposed to sera containing ASA against the same sperm suspensions exposed to control sera without ASA, using the in vitro cervical mucus penetration test [3]. Although a prominent role for IgA-ASA in impairing sperm penetration of cervical mucus was reported [10, 30, 52], other findings indicate that an abnormal interaction between the Fc portion of both IgA and IgG bound to the sperm surface and constituents of the cervical mucus is responsible for the impairment of mucus penetration and the shaking pattern of sperm motility observed in “in vitro” sperm-cervical mucus contact test (SCMC) [8]. Antibodies directed against the tail-tip do not impair sperm/cervical mucus interaction [52], and therefore have no role in infertility.


12.4.3 Complement-Mediated Cytotoxicity Through the Female Genital Tract


When spermatozoa coated with complement-fixing antibodies enter the female reproductive tract, they could undergo deleterious effects of complement activation, supposing that complement components are present in a sufficient amount through the female genital tract. In an old study by Price and Boettcher [43], although the level of complement activity in cervical mucus was only 11.5 % of the serum activity, this amount of complement was enough to cause complement-dependent immobilization of 50 % of ASA-coated spermatozoa in 1 h. Higher levels of complement activity were detected in human follicular fluid (one half of that in serum), and IgG-ASA were able to activate follicular fluid complement on human spermatozoa [16]. Due to the dilution of follicular fluid after ovulation, any sperm damage or dysfunction related “in vivo” to its complement activity is difficult to ascertain. Therefore, its clinical relevance is not proven.


12.4.4 Interference with Sperm/Egg Interaction


Although experimental “in vitro” studies have largely demonstrated that ASA can affect sperm functions involved in the sperm/egg interaction (see Chap. 3), the clinical relevance of these effects might be proven above all by the results of in vitro fertilization (IVF) as a model of study. In most reports, the overall fertilization rate was significantly lower in the presence of sperm-bound antibodies than in the case of other indications for IVF [2, 9, 12, 20, 36, 44, 50]. But, in some other reports no significant difference was found [14, 34, 48, 51]. In a meta-analysis by Zini et al. [57], including 10 studies (8 prospective and 2 retrospective), the presence of sperm-bound antibodies (with ASA cut-off value at direct tests ranging from 10 to 80 % as inclusion criterion) was not related to pregnancy rates after IVF: the combined OR for failure to achieve a pregnancy using IVF in the presence of ASA was 1.22 (95 % CI: 0.84, 1.77). However, the assessment of the actual interference of ASA on sperm fertilizing ability from the analysis of IFV results is hindered by the effect of concomitant nonimmunological sperm abnormalities and by the different degrees of sperm autoimmunization. Nevertheless, when the extent of sperm autoimmunization was taken into account, it was inversely correlated with the overall fertilization rate [17, 31, 41]. But, notably: (1) even when the percentage of fertilized oocytes was reduced in the presence of ASA, some oocytes were fertilized; (2) in some individual patients, a high fertilization rate was achieved even in the presence of a high extent of sperm autoimmunization.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 17, 2017 | Posted by in GYNECOLOGY | Comments Off on Male Autoimmune Infertility

Full access? Get Clinical Tree

Get Clinical Tree app for offline access